In What Sense is Digital Nature 'Nature'?The impact of 'nature with mass' accelerates the changes in 'nature without ...
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
Since the days of Dr. Alzheimer himself, there has been a dream that severe senility might have an explanation — and a cure. The search for both has never been more urgent. By Robert Kolker For his ...
Whether you use AI all the time or are a newcomer, the tech is changing so rapidly that it can be hard to keep up. Here are some of the key words that have been popping up in the news — and are likely ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Terry Taylor is worth about $2 billion, and you have almost surely never heard of him. Based in Florida, he doesn’t put his name on the car dealerships that he buys up, and he reportedly attends ...
Top executives at three of the nation’s leading AI labs are calling for a slowdown in the development of advanced artificial intelligence. The comments are a rare display of consensus among competing ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...